Molecule Structure

Scientific Name

Cangrelor

Description of the Drug

Cangrelor is a P2Y12 platelet receptor antagonist used during percutaneous coronary intervention to reduce the risk for periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST).

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06441

Brand Name(s)

Not Available

Company Owner(s)

Chiesi Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Purinergic receptor P2Y12 SINGLE PROTEIN ANTAGONIST CHEMBL2001

Unichem Links

SureChEMBL SCHEMBL6113860
PharmGKB PA165945763
Human Metabolome Database HMDB0240386
DrugBank DB06441
PubChem: Thomson Pharma 14889113 14840449
PubChem 9854012
Nikkaji J1.089.474C
BindingDB 50118225
EPA CompTox Dashboard DTXSID90167651
DrugCentral 5006
ChemicalBook CB62451277
Guide to Pharmacology 1776
rxnorm KENGREAL CANGRELOR CANGRELOR TETRASODIUM
ChEBI 90841
ZINC ZINC000085537017